Nevertheless, we did not observe a significant change in the CD4‐to‐CD8 ratio with recovery, suggesting that this parameter might be unbalanced independently of/prior to the disease and might, thus, identify a high‐risk population susceptible to lethal COVID‐19 complications. This evidence concerns the gene CD8A and COVID-19.